secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001493152-23-031982
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell Therapeutics amends articles after share exchange under arrangement
----------------------------------------------------------------------------

- Amended notice of articles and articles effective August 31, 2023.
- All existing BriaCell common shares exchanged for new shares with identical rights.
- Outstanding share count remains 15,981,726 following the exchange.
- Shareholders retain one vote per share and dividend/liquidation rights unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031982/0001493152-23-031982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031982/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer